Bank of New York Mellon’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bank of New York Mellon’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,010,631	Closed	-$42.6M	–	4428
2023 Q2	$42.6M	Sell	1,010,631 -23,022	-2%	-$931K	0.01%	1119
2023 Q1	$36.8M	Sell	1,033,653 -277,894	-21%	-$10.1M	0.01%	1188
2022 Q4	$48.1M	Buy	1,311,547 +5,284	+0.4%	+$209K	0.01%	1008
2022 Q3	$61.6M	Buy	1,306,263 +298,300	+30%	+$19.3M	0.01%	824
2022 Q2	$72.3M	Buy	1,007,963 +26,586	+3%	+$1.94M	0.02%	760
2022 Q1	$79.4M	Sell	981,377 -23,741	-2%	-$2.01M	0.02%	797
2021 Q4	$103M	Buy	1,005,118 +4,823	+0.5%	+$463K	0.02%	684
2021 Q3	$87.5M	Sell	1,000,295 -453,266	-31%	-$41M	0.02%	757
2021 Q2	$130M	Sell	1,453,561 -322,482	-18%	-$27.2M	0.03%	578
2021 Q1	$135M	Buy	1,776,043 +7,287	+0.4%	+$549K	0.03%	561
2020 Q4	$121M	Buy	1,768,756 +300,770	+20%	+$18.8M	0.03%	574
2020 Q3	$78M	Buy	1,467,986 +66,356	+5%	+$3.95M	0.02%	684
2020 Q2	$81.6M	Sell	1,401,630 -40,690	-3%	-$2.19M	0.02%	628
2020 Q1	$56.9M	Sell	1,442,320 -130,137	-8%	-$7.61M	0.02%	705
2019 Q4	$93.5M	Buy	1,572,457 +734,221	+88%	+$39.5M	0.02%	630
2019 Q3	$44.6M	Buy	838,236 +117,253	+16%	+$6.02M	0.01%	1017
2019 Q2	$36.8M	Buy	720,983 +9,625	+1%	+$448K	0.01%	1163
2019 Q1	$36.8M	Buy	711,358 +19,916	+3%	+$966K	0.01%	1166
2018 Q4	$27.2M	Sell	691,442 -8,667	-1%	-$403K	0.01%	1275
2018 Q3	$36.1M	Buy	700,109 +47,151	+7%	+$2.31M	0.01%	1243
2018 Q2	$30.6M	Buy	652,958 +26,267	+4%	+$1.09M	0.01%	1332
2018 Q1	$22.2M	Sell	626,691 -7,323	-1%	-$287K	0.01%	1506
2017 Q4	$27.6M	Sell	634,014 -71,208	-10%	-$3.33M	0.01%	1385
2017 Q3	$36.9M	Buy	705,222 +61,598	+10%	+$3.43M	0.01%	1178
2017 Q2	$37.7M	Buy	643,624 +364,329	+130%	+$18.9M	0.01%	1145
2017 Q1	$12.8M	Sell	279,295 -28,928	-9%	-$1.44M	﹤0.01%	1818
2016 Q4	$16.2M	Buy	308,223 +36,673	+14%	+$1.78M	﹤0.01%	1673
2016 Q3	$12.1M	Buy	271,550 +22,918	+9%	+$994K	﹤0.01%	1770
2016 Q2	$9.48M	Buy	248,632 +53,416	+27%	+$2.35M	﹤0.01%	1879
2016 Q1	$8.04M	Buy	195,216 +8,848	+5%	+$365K	﹤0.01%	1955
2015 Q4	$9.04M	Buy	186,368 +25,178	+16%	+$1.12M	﹤0.01%	1900
2015 Q3	$6.45M	Buy	161,190 +40,729	+34%	+$1.78M	﹤0.01%	2094
2015 Q2	$4.83M	Buy	120,461 +81,345	+208%	+$2.81M	﹤0.01%	2376
2015 Q1	$1.28M	Buy	39,116 +5,938	+18%	+$164K	﹤0.01%	3150
2014 Q4	$852K	Buy	+33,178	New	+$789K	﹤0.01%	3391

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of New York Mellon's SYNH Position: Q3 2023 in Review

Bank of New York Mellon sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,010,631 shares — an estimated $42.6M sold.

Bank of New York Mellon first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $135M in Q1 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Bank of New York Mellon reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of New York Mellon sold 1,010,631 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $42.6M.
Bank of New York Mellon first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Bank of New York Mellon's Syneos Health, Inc. Class A Common Stock position peaked at $135M in Q1 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.